Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
Collegium Pharmaceutical(COLL) stock is priced at $35.44, giving the company a market capitalization of 1.13B. It carries a P/E multiple of 20.43.
On 2026-03-21, Collegium Pharmaceutical(COLL) stock moved within a range of $35.27 to $36.58. With shares now at $35.44, the stock is trading +0.5% above its intraday low and -3.1% below the session's peak.
Trading activity shows a volume of 1.64M, compared to an average daily volume of 651.78K.
Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $50.79 and a low of $23.23.
Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $50.79 and a low of $23.23.
COLL News
Collegium Pharmaceutical ( (COLL) ) has provided an update. On March 19, 2026, Collegium Pharmaceutical announced a definitive agreement to acquire AZSTARYS, a...
(RTTNews) - Collegium Pharmaceutical, Inc. (COLL), a biopharmaceutical company, Thursday announced that it has agreed to acquire AZSTARYS for $650 million in ca...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.